Sekundo W, Bertelmann T, Schulze S
Augenklinik, Philipps Universität Marburg sowie Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg, Baldinger Str., 35043, Marburg, Deutschland,
Ophthalmologe. 2014 Apr;111(4):315-9. doi: 10.1007/s00347-013-2852-8.
Overview of the retropupillary implantation of iris claw intraocular lenses (Artisan®,Ophtec, Groningen, Niederlande and Verisyse(TM),AMO, Santa Ana CA).
A literature search and review of implantation techniques, patient selection, potential complications and management strategies.
This approach has the advantage of a simple implantation technique, an anatomically correct implantation site (as compared to endocapsular implantation) and a relatively low complication rate. An intact iris is, however, a prerequisite for this technique. Ischemic vitreoretinopathies, such as diabetes or vascular occlusive entities, as well as uveitis might be considered as contraindications.
The retropupillary implantation of iris claw intraocular lenses is an interesting and especially time-effective rehabilitation technique for aphakia.
虹膜爪型人工晶状体(Artisan®,Ophtec公司,荷兰格罗宁根;Verisyse(TM),AMO公司,美国加利福尼亚州圣安娜)瞳孔后植入的概述。
对植入技术、患者选择、潜在并发症及处理策略进行文献检索和综述。
该方法具有植入技术简单、植入位置解剖学上正确(与囊内植入相比)以及并发症发生率相对较低的优点。然而,完整的虹膜是该技术的前提条件。缺血性玻璃体视网膜病变,如糖尿病或血管阻塞性疾病,以及葡萄膜炎可能被视为禁忌证。
虹膜爪型人工晶状体瞳孔后植入是一种用于无晶状体眼的有趣且特别节省时间的康复技术。